Vitamin D Research
back to research menu
Cancer
- Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25‑hydroxyvitamin D and 1,25‑dihydroxyvitamin D, and prostate cancer risk.Prostate. 2007 Jun 15;67(9):911–23.
- Prospective study of serum 25(OH)‑vitamin D concentration and risk of oesophageal and gastric cancers.Br J Cancer. 2007 Jun 5;.
- Sun exposure and prostate cancer risk: evidence for a protective effect of early‑life exposure.Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1283–6.
- Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.Am J Clin Nutr. Vol. 85, No. 6, 1586–1591, June 2007
- Intakes of Calcium and Vitamin D and Breast Cancer Risk in Women.Arch Intern Med. 2007 May 28;167:1050–1059.
- Autophagy as a Mechanism of Radiation Sensitization in Breast Tumor Cells.Autophagy. 2007 May 19;3(3).
- Changes in risk of death from breast cancer with season and latitude : Sun exposure and breast cancer survival in Norway.Breast Cancer Res Treat. 2007 May;102(3):323–8. Epub 2006 Sep 21.
- Vitamin D and breast cancer.Ugeskr Laeger. 2007 Apr 2;169(14):1299–302. In Danish.
- Inhibition of lung carcinogenesis by 1alpha,25‑dihydroxyvitamin D(3) and 9‑cis retinoic acid in the A/J mouse model: Evidence of retinoid mitigation of vitamin D toxicity.Int J Cancer. 2007 Apr 1;120(7):1402–9.
- A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer.PLoS Med. 2007 March 20;4(3): e103.
- An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking.Int J Cancer. 2007 Mar 1;120(5):1123–8.
- A meta‑analysis of second cancers after a diagnosis of nonmelanoma skin cancer: Additional evidence that solar ultraviolet‑B irradiance reduces the risk of internal cancers.J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):668–74. Epub 2007 Jan 8.
- Optimal vitamin d status for colorectal cancer prevention a quantitative meta analysis.Am J Prev Med. 2007 Mar;32(3):210–6.
- Seasonal and geographical variations in lung cancer prognosis in Norway does Vitamin D from the sun play a role?Lung Cancer. 2007 Mar;55(3):263–70. Epub 2007 Jan 17.
- Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):302–7.
- Favourable and unfavourable effects of exposure to sunlight.Ned Tijdschr Geneeskd. 2007 Jan 13;151(2):118–22. Review In Dutch.
- Mutational Analysis of the Vitamin D Receptor Does Not Support Its Candidacy as a Tumor Suppressor Gene in Parathyroid Adenomas.Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 12 5019–5021.
- Vitamin D—an emerging issue in skin cancer control. Implications for public health practice based on the Australian experience.Recent Results Cancer Res. 2007;174:197–204. Review.
- Role of dihydroxyvitamin D(3) and its nuclear receptor in novel directed therapies for cancer.Gen Physiol Biophys. 2006 Dec;25 (4):339–53.
- Solar ultraviolet‑B exposure and cancer incidence and mortality in the United States, 1993–2002.BMC Cancer. 2006 Nov 10;6:264.
- The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E‑cadherin and vitamin D receptor in human colon carcinomas.Int J Cancer. 2006 Nov 1;119(9):2098–104.
- Phase I study of weekly DN‑101, a new formulation of calcitriol, in patients with cancer.Cancer Chemother Pharmacol. 2006 Oct 26;.
- CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer.Int J Cancer. 2006 Oct 15;119(8):1819–28.
- Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy.Int J Cancer. 2006 Oct 15;119(8):1902–7.
- Cancer survival is dependent on season of diagnosis and sunlight exposure.Int J Cancer. 2006 Oct 1;119(7):1530–6.
- UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States).Cancer Causes Control. 2006 Oct;17(8):1091–101.
- Ultraviolet radiation, dietary vitamin D, and risk of non‑Hodgkin lymphoma (United States).Cancer Causes Control. 2006 Oct;17(8):1045–52.
- Changes in risk of death from breast cancer with season and latitude: Sun exposure and breast cancer survival in Norway.Breast Cancer Res Treat. 2006 Sep 21;.
- Vitamin D Intake and the Risk for Pancreatic Cancer in Two Cohort Studies.Cancer Epidemiology Biomarkers & Prevention Vol. 15, 1688–1695, September 2006.
- Does sunlight prevent cancer? A systematic review.Eur J Cancer. 2006 Sep;42(14):2222–32. Epub 2006 Aug 10. Review.
- Does sunlight have a beneficial influence on certain cancers?Prog Biophys Mol Biol. 2006 Sep;92(1):132–9. Epub 2006 Feb 28. Review.
- Considering the potential benefits as well as adverse effects of sun exposure: Can all the potential benefits be provided by oral vitamin D supplementation?Prog Biophys Mol Biol. 2006 Sep;92(1):140–9. Epub 2006 Feb 28. Review.
- Vitamin D: its role in cancer prevention and treatment.Prog Biophys Mol Biol. 2006 Sep;92(1):49–59. Epub 2006 Mar 10. Review.
- Vitamin D physiology.Prog Biophys Mol Biol. 2006 Sep;92(1):4–8. Epub 2006 Feb 28. Review.
- Vitamin D deficiency: A global perspective.Arq Bras Endocrinol Metabol. 2006 Aug;50(4):640–6.
- UV radiation and cancer prevention: what is the evidence?Anticancer Res. 2006 Jul–Aug;26(4A):2723–7. Review.
- The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age‑adjusted cancer mortality rates.Anticancer Res. 2006 Jul–Aug;26(4A):2687–99.
- The likely role of vitamin D from solar ultraviolet‑B irradiance in increasing cancer survival.Anticancer Res. 2006 Jul–Aug;26(4A):2605–14.
- Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.Anticancer Res. 2006 Jul–Aug;26(4A):2567–72.
- Vitamin D and cancer.Anticancer Res. 2006 Jul–Aug;26(4A):2515–24. Review.
- A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone‑refractory prostate cancer.Cancer. 2006 Jun 15;
- Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer.Int J Cancer. 2006 Jun 15;118(12):3140–6.
- Cooperative antitumor effects of vitamin D(3) derivatives and rosemary preparations in a mouse model of myeloid leukemia.Int J Cancer. 2006 Jun 15;118(12):3012–21.
- Phase II trial of high‑dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen‑independent prostate cancer.Cancer. 2006 May 15;106(10):2136–42.
- Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.J Natl Cancer Inst. 2006 Apr 5;98(7):451–9.
- Human Mammary Epithelial Cells Express CYP27B1 and Are Growth Inhibited by 25‑Hydroxyvitamin D‑3, the Major Circulating Form of Vitamin D‑3.J Nutr. 2006 Apr;136(4):887–92.
- 1,25‑Dihydroxyvitamin D(3) inhibits tumor necrosis factor‑alpha‑induced adhesion molecule expression in endothelial cells.Cell Biol Int. 2006 Mar 17;
- The Molecular Basis of Vitamin D Receptor and beta‑Catenin Crossregulation.Mol Cell. 2006 Mar 17;21(6):799–809.
- Vitamin D: Its role in cancer prevention and treatment.Prog Biophys Mol Biol. 2006 Mar 10; Review.
- Calcium plus vitamin D supplementation and the risk of colorectal cancer.N Engl J Med. 2006 Feb 16;354(7):684–96.
- The Role of Vitamin D in Cancer Prevention.Am J Public Health. 2006 Feb;96(2):252–61. Epub 2005 Dec 27. Review.
- A prospective study of calcium intake and incident and fatal prostate cancer.Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):203–10.
- Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer.Int J Cancer. 2006 Jan 19;
- Vitamin D analogs as anti‑carcinogenic agents.Anticancer Agents Med Chem. 2006 Jan;6(1):53–71. Review.
- The epidemiology of vitamin D and colorectal cancer: recent findings.Curr Opin Gastroenterol. 2006 Jan;22(1):24–9. Review.
- Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men.Int Urol Nephrol. 2006;38(1):33–44.
- Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer.Nutr Cancer. 2006;56(1):22–30.
- Phase I/II study of 19‑nor‑1alpha‑25‑dihydroxyvitamin D2 (paricalcitol) in advanced, androgen‑insensitive prostate cancer.Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8680–5.
- Upregulation of 25‑hydroxyvitamin D(3)‑1(alpha)‑hydroxylase by butyrate in Caco‑2 cells.World J Gastroenterol. 2005 Dec 7;11(45):7136–41.
- UpMutational Analysis of the Vitamin D Receptor Does Not Support Its Candidacy as a Tumor Suppressor Gene in Parathyroid Adenomas.Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 12 5019–5021.
- Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort.Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2898–904.
- Ultraviolet Radiation, Vitamin D and Risk of Prostate Cancer and Other Diseases.Photochem Photobiol. 2005 Nov–Dec;81(6):1252–60. Review.
- E‑cadherin and vitamin D receptor regulation by Snail and Zeb1 in colon cancer: clinicopathological correlations.Hum Mol Genet. 2005 Nov 15;14(22):3361–70. Epub 2005 Oct 3.
- Non‑genomic effects of the androgen receptor and Vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells.Steroids. 2005 Nov 8;
- Pharmacokinetics and tolerability of a single dose of DN‑101, a new formulation of calcitriol, in patients with cancer.Clin Cancer Res. 2005 Nov 1;11(21):7794–9.
- Vitamin D3 treatment for locally advanced thyroid cancer: a case report.Endocr J. 2005 Oct;52(5):613–6.
- Vitamin D deficiency enhances the growth of MC‑26 colon cancer xenografts in Balb/c mice.J Nutr. 2005 Oct;135(10):2350–4.
- Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs.J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):111–20. Epub 2005 Sep 8.
- The Vitamin D endocrine system of the gut—its possible role in colorectal cancer prevention.J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):121–8. Epub 2005 Aug 2.
- Dietary recommendations to meet both endocrine and autocrine needs of Vitamin D.J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):7–12. Epub 2005 Jul 25. Review.
- Inhibitory effect of 22‑oxa‑1,25‑dihydroxyvitamin D3, maxacalcitol, on the proliferation of pancreatic cancer cell lines.J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):173–7. Epub 2005 Jul 20.
- Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun‑induced vitamin D.Br J Cancer. 2005 Sep 5;93(5):571–4.
- High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study.J Urol. 2005 Sep;174(3):888–92.
- Vitamin D and the epidemiology of prostate cancer.Semin Dial. 2005 Jul–Aug;18(4):276–89. Review.
- Benefits and requirements of vitamin D for optimal health: a review.Altern Med Rev. 2005 Jun;10(2):94–111. Review.
- Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow‑up Study cohort.Am J Clin Nutr. 2005 May;81(5):1147–54.
- Intakes of calcium and vitamin D and risk of colorectal cancer in women.Am J Epidemiol. 2005 Apr 15;161(8):755–64.
- Snail vs vitamin D receptor expression in colon cancer: therapeutics implications. British Journal of Cancer. 2005 March 15;92:985–989.
- The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).Cancer Causes Control. 2005 Mar;16(2):83–95. Review.
- Vitamin D and the elderly.Clin Endocrinol (Oxf). 2005 Mar;62(3):265–81. Review.
- Seasonal variation in the diagnosis of cutaneous melanoma and non‑cutaneous malignancies: an Italian population‑based study.Melanoma Res. 2005 Feb;15(1):69–72.
- The association of calcium and vitamin D with risk of colorectal adenomas.J Nutr. 2005 Feb;135(2):252–9.
- Cholecalciferol (vitamin D3) inhibits growth and invasion by up‑regulating nuclear receptors and 25‑hydroxylase (CYP27A1) in human prostate cancer cells.Clin Exp Metastasis. 2005;22(3):275–84.
- Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25‑hydroxylase (CYP27A1) in human prostate epithelial cells.Clin Exp Metastasis. 2005;22(3):265–73.
- Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‑regulated in myeloid cells by 1,25‑dihydroxyvitamin D3.FASEB. 2005;19:1067–1077.
- Inhibition of proliferation and induction of apoptosis by 25‑hydroxyvitamin D3‑3beta‑(2)‑Bromoacetate, a nontoxic and vitamin D receptor‑alkylating analog of 25‑hydroxyvitamin D3 in prostate cancer cells.Clin Cancer Res. 2004 Dec 1;10(23):8018–27.
- Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S–88S. Review.
- Sun exposure may protect against non‑Hodgkin lymphoma: a case‑control study.Int J Cancer. 2004 Dec 10;112(5):865–71.
- The role of Vitamin D3 metabolism in prostate cancer.J Steroid Biochem Mol Biol. 2004 Nov;92(4):317–25. Epub 2004 Dec 19. Review.
- Toxicity and antineoplastic effect of (24R)‑1,24‑dihydroxyvitamin D3 (PRI‑2191).Steroids. 2004 Sep;69(10):629–35.
- Plasma 1,25‑dihydroxy‑ and 25‑hydroxyvitamin D and subsequent risk of prostate cancer.Cancer Causes Control. 2004 Apr;15(3):255–65.
- Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):546–52.
- A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality.Eur Urol. 2004 Mar;45(3):271–9.
- Vitamin D3 from sunlight may improve the prognosis of breast‑, colon‑ and prostate cancer (Norway).Cancer Causes Control. 2004 Mar;15(2):149–58.
- A critical review of studies on vitamin D in relation to colorectal cancer.Nutr Cancer. 2004;48(2):115–23. Review.
- Serum levels of prostate‑specific antigen and vitamin D in peritoneal dialysis patients.Adv Perit Dial. 2004;20:203–8.
- Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer.Environ Mol Mutagen. 2004;43(2):121–7.
- Vitamin D and prostate cancer prevention and treatment.Trends Endocrinol Metab. 2003 Nov;14(9):423–30. Review.
- Vitamin D enhances caspase‑dependent and ‑independent TNFalpha‑induced breast cancer cell death: The role of reactive oxygen species and mitochondria.Int J Cancer. 2003 Aug 20;106(2):178–86.
- Ultraviolet radiation: sun exposure, tanning beds, and vitamin D levels. What you need to know and how to decrease the risk of skin cancer. J Am Osteopath Assoc. 2003 Aug;103(8):371–5. Review.
- Micronutrients and laryngeal cancer risk in Italy and Switzerland: a case‑control study.Cancer Causes Control. 2003 Jun;14(5):477–84.
- Susceptibility to prostate cancer: studies on interactions between UVR exposure and skin type.Carcinogenesis. 2003 Apr;24(4):711–7.
- Prostate cancer risk and exposure to ultraviolet radiation: further support for the protective effect of sunlight.Cancer Lett. 2003 Mar 31;192(2):145–9.
- Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States).Cancer Causes Control. 2003 Feb;14(1):1–12.
- Ecologic studies of solar UVB radiation and cancer mortality rates.Recent Results Cancer Res. 2003;164:371–7. Review.
- Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells.Recent Results Cancer Res. 2003;164:99–110. Review.
- Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.Recent Results Cancer Res. 2003;164:273–88.
- Vitamin D analogs and breast cancer.Recent Results Cancer Res. 2003;164:333–48. Review.
- Vitamin D autocrine system and prostate cancer.Recent Results Cancer Res. 2003;164:223–37. Review.
- Pharmacokinetics of high‑dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel.Clin Pharmacol Ther. 2002 Dec;72(6):648–59.
- Vitamin D3 and vitamin D3 analogues as an adjunct to cancer chemo‑therapy and radiotherapy.Curr Med Chem Anti‑Canc Agents. 2002 Nov;2(6):683–90. Review.
- Intake of dairy products, calcium, and vitamin d and risk of breast cancer.Natl Cancer Inst. 2002 Sep 4;94(17):1301–11.
- Vitamin D and systemic cancer: is this relevant to malignant melanoma?Br J Dermatol. 2002 Aug;147(2):197–213. Review.
- Cisplatin Potentiates 1,25‑Dihydroxyvitamin D3‑induced Apoptosis in Association with Increased Mitogen‑activated Protein Kinase Kinase Kinase 1 (MEKK‑1) Expression1.Vol. 1, 821–829, August 2002 Molecular Cancer Therapeutics.
- Sunlight and mortality from breast, ovarian, colon, prostate, and non‑melanoma skin cancer: a composite death certificate based case‑control study.Occup Environ Med. 2002 Apr;59(4):257–62.
- New clues about vitamin D functions in the nervous system.Trends Endocrinol Metab. 2002 Apr;13(3):100–5. Review.
- An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet‑B radiation.Cancer. 2002 Mar 15;94(6):1867–75.
- Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer.Endocr Relat Cancer. 2002 Mar;9(1):45–59. Review.
- Vitamin D and vitamin D analogs in cancer treatment.Curr Drug Targets. 2002 Feb;3(1):85–94. Review.
- Colonic epithelial cell proliferation decreases with increasing levels of serum 25‑hydroxy vitamin D.Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):113–9. Erratum in: Cancer Epidemiol Biomarkers Prev 2002 May;11(5):501.
- Vitamin D‑related therapies in prostate cancer.Cancer Metastasis Rev. 2002;21(2):147–58. Review.
- Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women.Nutr Cancer. 2002;43(1):39–46.
- Outcome in prostate cancer associations with skin type and polymorphism in pigmentation‑related genes.Carcinogenesis. 2001 Sep;22(9):1343–7.
- 25‑hydroxyvitamin D‑1alpha‑hydroxylase in normal and malignant colon tissue.Lancet. 2001 May 26;357(9269):1673–4. Letter.
- Vitamin D and genomic stability.Mutat Res. 2001 Apr 18;475(1–2):69–87. Review.
- Vitamin D and prostate cancer.J Steroid Biochem Mol Biol. 2001 Jan–Mar;76(1–5):125–34.
- Cancer chemoprevention using natural vitamin D and synthetic analogs.Annu Rev Pharmacol Toxicol. 2001;41:421–42. Review.
- Prevention of N‑methyl‑N‑nitrosourea‑induced mammary carcinogenesis in rats by 1alpha‑hydroxyvitamin D(5).J Natl Cancer Inst. 2000 Nov 15;92(22):1836–40.
- Prostate cancer risk and prediagnostic serum 25‑hydroxy vitamin D levels (Finland).Cancer Causes Control. 2000 Oct;11(9):847–52.
- Plasma 1,25‑dihydroxy‑ and 25‑hydroxyvitamin D and adenomatous polyps of the distal colorectum.Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1059–65.
- Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma.Clin Cancer Res. 2000 Feb;6(2):498–504.
- Environmental factors in nonmelanoma and melanoma skin cancer.J Epidemiol. 1999 Dec;9(6 Suppl):S102–14. Review.
- Skin cancer and solar UV radiation.Eur J Cancer. 1999 Dec;35(14):2003–9. Review.
- Vitamin D, calcium and prevention of breast cancer: a review.J Am Coll Nutr. 1999 Oct;18(5 Suppl):392S–397S. Review.
- A hypothesis concerning deficiency of sunlight, cold temperature, and influenza epidemics associated with the onset of acute lymphoblastic leukemia in northern Finland.Ann Hematol. 1999 Sep;78(9):408–14.
- In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma.Cancer. 1999 Aug 1;86(3):391–7.
- Vitamin D and prostate cancer.Proc Soc Exp Biol Med. 1999 Jun;221(2):89–98. Review.
- Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow‑up study, 1971–1975 to 1992. National Health and Nutrition Examination Survey.Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):399–406.
- Studies of calcium in food supplements in humans.Ann N Y Acad Sci. 1999;889:128–37. Review.
- Calcium and vitamin D. Their potential roles in colon and breast cancer prevention.Ann N Y Acad Sci. 1999;889:107–19. Review.
- Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis.Cancer Causes Control. 1998 Dec;9(6):567–82. Review.
- Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden).Cancer Causes Control. 1998 Dec;9(6):559–66.
- Human prostate cells synthesize 1,25‑dihydroxyvitamin D3 from 25‑hydroxyvitamin D3.Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):391–5.
- Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):385–90.
- Intake of selected micronutrients and risk of colorectal cancer.Cancer Epidemiol Int J Cancer. 1997 Nov 14;73(4):525–30.
- Vitamin D3 analogs and their 24‑oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.J Cell Biochem. 1997 Sep 1;66(3):413–25.
- Inhibition of proliferation of prostate cancer cells by a 19‑nor‑hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E‑cadherin.J Mol Endocrinol. 1997 Aug;19(1):15–27.
- Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men.Cancer Causes Control. 1997 Jul;8(4):615–25.
- Residential and occupational exposure to sunlight and mortality from non‑Hodgkin's lymphoma: composite (threefold) case‑control study.BMJ. 1997 May 17;314(7092):1451–5.
- Vitamin D metabolism in human colon adenocarcinoma‑derived Caco‑2 cells: expression of 25‑hydroxyvitamin D3‑1alpha‑hydroxylase activity and regulation of side‑chain metabolism.J Steroid Biochem Mol Biol. 1997 May;62(1):21–8.
- Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha‑hydroxyvitamin D5.J Natl Cancer Inst. 1997 Feb 5;89(3):212–8.
- Calcium, vitamin D, and the occurrence of colorectal cancer among women.J Natl Cancer Inst. 1996 Oct 2;88(19):1375–82.
- Association of prostate cancer with vitamin D receptor gene polymorphism.Cancer Res. 1996 Sep 15;56(18):4108–10.
- Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA‑1: evidence that the antiproliferative effects of 1 alpha, 25‑dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.Endocrinology. 1996 May;137(5):1554–61.
- Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men.Am J Epidemiol. 1996 May 1;143(9):907–17.
- Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):121–6.
- Characterization of a vitamin D3‑resistant MCF‑7 cell line.Endocrinology. 1996 Feb;137(2):400–9.
- Sunlight—can it prevent as well as cause cancer?Cancer Res. 1995 Sep 15;55(18):4014–22. Review.
- Treating tumor‑bearing mice with vitamin D3 diminishes tumor‑induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence.Cancer Immunol Immunother. 1995 Jul;41(1):37–45.
- Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)Cancer Causes Control. 1995 May;6(3):235–9.
- Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25‑dihydroxyvitamin D3.Endocrinology. 1995 Jan;136(1):20–6.
- Vitamin D and prostate cancer.Adv Exp Med Biol. 1995;375:53–63. Review.
- Sunlight, vitamin D, and ovarian cancer mortality rates in US women.Int J Epidemiol. 1994 Dec;23(6):1133–6.
- Interspecies comparative pathology of colorectal neoplasms: relevance for treatment.In Vivo. 1994 Nov–Dec;8(5):893–914.
- Sun exposure and non‑melanocytic skin cancer.Cancer Causes Control. 1994 Jul;5(4):367–92. Review.
- Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies.Am J Epidemiol. 1994 Jan 1;139(1):16–29.
- Vitamin D and prostate cancer: a prediagnostic study with stored sera.Cancer Epidemiol Biomarkers Prev. 1993 Sep–Oct;2(5):467–72.
- Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa Women's Health Study.Am J Epidemiol. 1993 Jun 15;137(12):1302–17. Review.
- Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.Endocrinology. 1993 May;132(5):1952–60.
- Beneficial effects of sun exposure on cancer mortality.Prev Med. 1993 Jan;22(1):132–40. Review.
- Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation.Cancer. 1992 Dec 15;70(12):2861–9.
- Colorectal cancer and solar radiation.Cancer Causes Control. 1992 Jan;3(1):95–9.
- Multiple sclerosis and prostate cancer: what do their similar geographies suggest?Neuroepidemiology. 1992;11(4–6):244–54.
- Can colon cancer incidence and death rates be reduced with calcium and vitamin D?Am J Clin Nutr. 1991 Jul;54(1 Suppl):193S–201S. Review.
- Sunlight and breast cancer incidence in the USSR.Int J Epidemiol. 1990 Dec;19(4):820–4.
- Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation.Prev Med. 1990 Nov;19(6):614–22.
- Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).Anticancer Res. 1990 Sep–Oct;10(5A):1307–11.
- Serum 25‑hydroxyvitamin D and colon cancer: eight‑year prospective study.Lancet. 1989 Nov 18;2(8673):1176–8.
- Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25‑dihydroxyvitamin D3.Cancer Res. 1987 Jan 1;47(1):21–5.
- Seasonality of presentation of cutaneous melanoma, squamous cell cancer and basal cell cancer in the Oxford Region.Br J Cancer. 1985 Dec;52(6):893–900.
- Dietary vitamin D and calcium and risk of colorectal cancer: a 19‑year prospective study in men.Lancet. 1985 Feb 9;1(8424):307–9.
- Do sunlight and vitamin D reduce the likelihood of colon cancer?Int J Epidemiol. 1980 Sep;9(3):227–31.
back to research menu